Data / Form D filings / Curve Biosciences, Inc.
Curve Biosciences, Inc.: Form D filing
Curve Biosciences, Inc., a company in Mountain View, CA, filed a Form D with the SEC in 2024. The latest, on May 13, 2024, reports $17.7 million sold of a $20 million offering to 64 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 319 N. BERNARDO AVENUE, Mountain View, CA, 94043
- Phone
- (214) 680-9460
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2023059
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2024 | New notice | $20,038,985 | $17,691,996 | $2,346,989 | 64 | May 1, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CHUBA OYOLU | Executive Officer | |
| NATHAN HUNKAPILLER | Executive Officer | |
| SHAN XIANG WANG | Executive Officer, Director | |
| THEMASAP KHAN | Director | |
| RITISH PATNAIK | Executive Officer, Director |
Other companies in California that filed recently
- MoFlo Acquisitions, Inc. $587.5 million · Nov 2, 2026
- BC Movie, LLC offering · Nov 2, 2026
- Jana Education San Jose LLC $200,000 · Nov 2, 2026
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
Every Form D from the week of May 13, 2024 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Curve Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.